NCT07152262

Brief Summary

This study aims to investigate the effects of different phases of the menstrual cycle on gait spatiotemporal characteristics, pelvic kinematics, and sleep quality in healthy women aged 18-35 years with regular menstrual cycles. Participants will be assessed in three phases of the cycle: early follicular (days 1-3), ovulation (days 7-9, confirmed by ovulation test), and luteal (days 20-23). Gait parameters and pelvic kinematics will be evaluated using the BTS-G walk sensor system, while sleep quality will be assessed with the Pittsburgh Sleep Quality Index (PSQI). The study seeks to determine whether physiological and hormonal changes during menstrual phases lead to measurable differences in gait, pelvic motion, and sleep quality.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 3, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2026

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

January 9, 2026

Status Verified

January 1, 2026

Enrollment Period

8 months

First QC Date

August 26, 2025

Last Update Submit

January 8, 2026

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in Gait Speed Across Menstrual Phases

    Within-subject change in comfortable gait speed (meters/second (m/s)) measured by BTS-G walk sensor in three phases: early follicular (days 1-3), ovulation (days 7-9; salivary test-confirmed), luteal (days 20-23).

    Within one menstrual cycle (~3-4 weeks).

  • Change in Cadence Across Menstrual Phases

    Within-subject change in step cadence( steps/min) recorded by BTS-G walk across the same three phases.

    Within one menstrual cycle (~3-4 weeks).

  • Change in Stride Length Across Menstrual Phases

    Within-subject change in stride length (centimeters/cm) captured by BTS-G walk across the three phases.

    Within one menstrual cycle (~3-4 weeks).

  • Change in Stance and Swing Phase Percentages

    Within-subject change in stance (%) and swing (%) durations during gait across phases using BTS-G walk.

    Within one menstrual cycle (~3-4 weeks).

  • Change in Pelvic Kinematics

    Within-subject change in pelvic tilt (degree), obliquity (degree), and rotation symmetry (degree) indices obtained from BTS-G walk across phases.

    Within one menstrual cycle (~3-4 weeks).

  • Change in Sleep Quality

    Within-subject change in Pittsburgh Sleep Quality Index (PSQI) global score across phases. The PSQI is scored between 0 and 21. Higher scores indicate poorer sleep quality.

    Within one menstrual cycle (~3-4 weeks).

Study Arms (1)

Healthy Women with Regular Menstrual Cycles

Women aged 18-35 years with regular menstrual cycles (28 ± 7 days), evaluated prospectively during early follicular, ovulation, and luteal phases.

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy women aged 18-35 years with regular menstrual cycles (28 ± 7 days). Participants will be assessed during three phases of their menstrual cycle (early follicular, ovulation, and luteal) to examine changes in gait parameters, pelvic kinematics, and sleep quality.

You may qualify if:

  • Female, aged 18-35 years
  • Voluntarily agrees to participate and provides informed consent
  • Regular menstrual cycle (28 ± 7 days)
  • Able to comply with study assessments and procedures

You may not qualify if:

  • History of surgery within the past 6 months
  • Current or chronic low back pain
  • Dysmenorrhea complaints
  • Neurological or orthopedic disorders affecting gait or muscle strength
  • Presence of spinal deformities
  • Rheumatologic disease
  • Climacteric or menopausal period
  • Any condition that may affect gait, pelvic kinematics, or sleep quality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yuksek Ihtisas University

Ankara, Turkey (Türkiye)

RECRUITING

Study Officials

  • Aylin Baykal

    Yuksek Ihtisas University

    PRINCIPAL INVESTIGATOR
  • Busra Kalkan Balak

    Yuksek Ihtisas University

    STUDY DIRECTOR
  • Gungor Beyza Ozvar Senoz

    Yuksek Ihtisas University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gungor Beyza Ozvar Senoz

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 26, 2025

First Posted

September 3, 2025

Study Start

June 1, 2025

Primary Completion

January 20, 2026

Study Completion

February 1, 2026

Last Updated

January 9, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations